You are here: Industry Insights > Takeda

News List

Takeda forms new alliances to boosts immuno-oncology portfolio pharmaceutical-technology
January 07, 2019
Takeda Pharmaceutical has formed new research alliances to bolster the discovery of next-generation immunotherapies, including cell therapy techniques, for the treatment of cancer......
GARDP, Eisai and Takeda join forces to identify new antibiotics pharmaceutical-technology
December 13, 2018
The Global Antibiotic Research and Development Partnership (GARDP) in Switzerland has partnered with Eisai and Takeda Pharmaceutical in a bid to discover new antibiotics.....
M&As : GlaxoSmithKline, Takeda, Procter & Gamble pharmaceutical-technology
December 10, 2018
GlaxoSmithKline (GSK) has agreed to acquire US-based cancer treatment developer Tesaro for $5.1bn.GSK will acquire all issued and outstanding.....
Takeda shareholders approve $62bn Shire acquisition pharmafile
December 07, 2018
Japanese firm Takeda have gained shareholders’ approval for the $62 billion acquisition of the Irish headquartered company Shire Plc.
Shire purchase backed by Takeda shareholders pharmatimes
December 07, 2018
Takeda announced in May this year a deal to buy the firm, after having its merger proposals previously turned down four times by Shire.
Takeda receives shareholders’ approval to acquire Shire pharmaceutical-technology
December 06, 2018
Takeda Pharmaceutical has secured shareholder approval for the issuance of its shares necessary to implement the proposed $62bn acquisition of Shire....
Takeda ex-chairman speaks out against Shire buy a week before key votes fiercepharma
December 06, 2018
Just a week ahead of the final shareholder votes on Takeda’s $62 billion acquisition of Shire, a former Takeda chairman and the last member of the founding family to have run the Japanese pharma has come forward against the deal.
Takeda CEO gets his Shire megamerger, thanks to shareholder nod. Can he make it pay off? fiercepharma
December 06, 2018
Behold, Takeda can soon call itself a Big Pharma. Its shareholders joined Shire’s in separately approving the mega-M&A deal, despite opposition from a small group of dissidents...
Takeda maintenance data set up Ninlaro for new myeloma nod fiercepharma
December 05, 2018
Takeda’s Ninlaro has watched from the sidelines as competing multiple myeloma drugs jumped into additional indications. But now it may finally be ready to do the same.
Takeda could rack up $10B in selloffs after controversial Shire buyout: report fiercepharma
December 04, 2018
With a crucial shareholder vote looming, Takeda is on an aggressive push to win investor support for a Shire buyout expected to load the company with debt. Now, a top executive says that debt burden could be $10 billion lighter after the deal closes.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 28 29 Next page